Related Experiment Videos
Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition
1Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, USA.
Journal of Pharmaceutical Sciences
|February 15, 2001
Abstract:
Oxidation is a common pathway for drug degradation in liquid and solid formulations. The present article reviews mechanistic details of autoxidation and chain oxidation processes, as well as the oxidation of selected functional groups commonly affected in drugs.
Insights
Drug oxidation is a major cause of degradation in various formulations. This review details autoxidation, chain oxidation, and the impact on common drug functional groups.
Area of Science:
- Pharmaceutical Chemistry
- Drug Stability
- Oxidative Degradation
Background:
- Oxidation is a significant factor in drug degradation.
- This process affects both liquid and solid drug formulations.
- Understanding oxidation mechanisms is crucial for drug development.
Purpose of the Study:
- To review the mechanistic details of drug autoxidation.
- To examine chain oxidation processes in drug degradation.
- To discuss the oxidation of common drug functional groups.
Main Methods:
- Literature review of oxidation mechanisms.
- Analysis of autoxidation and chain oxidation pathways.
- Identification of frequently oxidized functional groups in pharmaceuticals.
Main Results:
- Detailed mechanistic insights into autoxidation and chain oxidation are presented.
- Commonly affected drug functional groups are identified and discussed.
- The review synthesizes current knowledge on drug oxidation pathways.
Conclusions:
- Oxidative degradation is a critical concern for drug stability.
- Understanding these mechanisms aids in developing more stable drug formulations.
- Further research into preventing drug oxidation is warranted.